PHARMAVEST ApS: Financial statements 2025
CVR: 26385180
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PHARMAVEST ApS (CVR 26385180) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. That is a decrease of 57.8% compared with the year before. Equity in the 2025 report amounted to DKK 4,349,573. The solvency ratio was 76.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 812,233
- Profit/Loss
- DKK -167,231
- Equity
- DKK 4,349,573
- Total Assets
- DKK 5,683,810
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 812 t. | -167 t. | 4.3 mio. | 1 |
| 2024 | - | 1.9 mio. | 271 t. | 5.5 mio. | 1 |
| 2023 | - | 2 mio. | 1 mio. | 5.7 mio. | 1 |
| 2022 | - | 1.8 mio. | 680 t. | 4.9 mio. | 1 |
| 2021 | - | 1.8 mio. | 618 t. | 4.3 mio. | 1 |
Official annual report
How creditworthy is PHARMAVEST ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
PHARMAVEST ApS has published its annual report for 2024. Gross profit came to DKK 1,925,932, and the net result was DKK 271,222.
About PHARMAVEST ApS
PHARMAVEST ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named PHARMAVEST A/S and PBH 28.037 ApS. The management consists of Frank Orluff Lydig Kristensen. The company is owned by FRANK LYDIG HOLDING ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 812,233 and a net result of DKK -167,231 compared with DKK 271,222 the year before. Equity in the 2025 report amounted to DKK 4,349,573.